The risks of sharing your DNA with online companies aren’t a future concern. They’re here now
By Nila Bala,
Los Angeles Times
| 10. 21. 2024
Turmoil at 23andMe, a company offering popular at-home DNA testing, has upset the industry. Following the resignation of every independent member of the company’s board of directors, its chief executive, Anne Wojcicki, expressed openness to selling the company and its database of around 15 million customers, raising concerns about the misuse of genetic data.
Although Wojcicki has since said she is focused on taking 23andMe private, the data-sharing risks raised by DNA testing and matching companies are already here. A class-action lawsuit filed in August alleges that the operator of GEDmatch.com, a genealogy site that claims to have a database of more than 1 million members, has been sharing users’ information with Facebook. This revelation should alarm us all.
GEDmatch stands apart from companies such as 23andMe. It’s an open, crowdsourced database that anyone can search. Founded in 2010, it emerged as a tool for genealogy enthusiasts to upload DNA results and connect with relatives. It gained notoriety when law enforcement officials announced in 2018 that they had used the service to identify the Golden State...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...
